The trademark ORQELLIS was filed by ESTEVE PHARMACEUTICALS, S.A., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on August 5, 2020, and received one opposition filed on November 1, 2020 by BIOFARMA on Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 1, 2020
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
The Opposition with reference B 003133753 was refused according to Article 8(1)(b) EUTMR with decision issued on March 1, 2022 by the EUIPO.